Ceftaroline: Before Start of Using in Russia | CMAC

Ceftaroline: Before Start of Using in Russia

Clinical Microbiology and Antimicrobial Chemotherapy. 2013; 15(3):212-218

Section
Type
Journal article

Abstract

Bacteriological and clinical data on the novel cephalosporin antibiotic ceftarolin fosamil is reviewed. Ceftarolin may be considered as promising drug in Russia due to potent anti-MRSA and antipneumococcal activity, broad spectrum and low toxicity.

Views
0 Abstract
0 PDF
0 Crossref citations
Shared